Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.

Objective: To describe the participation of minority women in clinical trials using immunologic agents for breast and gynecologic cancers.

Methods: A retrospective review of completed clinical trials involving immunotherapy for breast and gynecologic cancers was performed. Completed trials were examined for data on race, tumor type, and start year.